SALMON EVOLUTION ASA (SALME.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:SALME - NO0010892094 - Common Stock
5.06 NOK
-0.08 (-1.56%)
We assign a fundamental rating of 2 out of 10 to SALME. SALME was compared to 60 industry peers in the Food Products industry. Both the profitability and financial health of SALME have multiple concerns. SALME is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year SALME has reported negative net income.
SALME had a negative operating cash flow in the past year.
In the past 5 years SALME always reported negative net income.
In the past 5 years SALME reported 4 times negative operating cash flow.
1.2 Ratios
SALME has a Return On Assets of -5.15%. This is in the lower half of the industry: SALME underperforms 78.33% of its industry peers.
The Return On Equity of SALME (-8.41%) is worse than 76.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.15% | ||
| ROE | -8.41% | ||
| ROIC | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 62.88%, SALME belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
SALME's Gross Margin has declined in the last couple of years.
SALME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SALME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SALME has been increased compared to 1 year ago.
Compared to 5 years ago, SALME has more shares outstanding
The debt/assets ratio for SALME has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 0.92, we must say that SALME is in the distress zone and has some risk of bankruptcy.
SALME's Altman-Z score of 0.92 is on the low side compared to the rest of the industry. SALME is outperformed by 78.33% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that SALME is not too dependend on debt financing.
SALME has a better Debt to Equity ratio (0.41) than 68.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.92 |
ROIC/WACCN/A
WACC7.85%
2.3 Liquidity
A Current Ratio of 0.96 indicates that SALME may have some problems paying its short term obligations.
SALME's Current ratio of 0.96 is on the low side compared to the rest of the industry. SALME is outperformed by 70.00% of its industry peers.
SALME has a Quick Ratio of 0.96. This is a bad value and indicates that SALME is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SALME (0.53) is worse than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
SALME shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -152.94%.
The Revenue has grown by 205.07% in the past year. This is a very strong growth!
The Revenue has been growing by 238.62% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-152.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)205.07%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%68.54%
3.2 Future
The Earnings Per Share is expected to grow by 81.13% on average over the next years. This is a very strong growth
SALME is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 37.55% yearly.
EPS Next Y-330.73%
EPS Next 2Y0.84%
EPS Next 3Y50.21%
EPS Next 5Y81.13%
Revenue Next Year-27.75%
Revenue Next 2Y15.64%
Revenue Next 3Y39.62%
Revenue Next 5Y37.55%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SALME. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SALME. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as SALME's earnings are expected to grow with 50.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.84%
EPS Next 3Y50.21%
5. Dividend
5.1 Amount
No dividends for SALME!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OSL:SALME (1/9/2026, 7:00:00 PM)
5.06
-0.08 (-1.56%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners22.98%
Inst Owner ChangeN/A
Ins Owners2.16%
Ins Owner ChangeN/A
Market Cap2.34B
Revenue(TTM)467.74M
Net Income(TTM)-176.66M
Analysts86.25
Price Target7.82 (54.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-215.55%
Min EPS beat(2)-220.42%
Max EPS beat(2)-210.68%
EPS beat(4)1
Avg EPS beat(4)-422.53%
Min EPS beat(4)-1265.05%
Max EPS beat(4)6.04%
EPS beat(8)2
Avg EPS beat(8)-223.01%
EPS beat(12)5
Avg EPS beat(12)-150.61%
EPS beat(16)9
Avg EPS beat(16)-104.98%
Revenue beat(2)0
Avg Revenue beat(2)-30.39%
Min Revenue beat(2)-43.93%
Max Revenue beat(2)-16.84%
Revenue beat(4)1
Avg Revenue beat(4)-23.17%
Min Revenue beat(4)-43.93%
Max Revenue beat(4)1.98%
Revenue beat(8)3
Avg Revenue beat(8)-20.9%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.48%
PT rev (3m)-7.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-13.38%
EPS NY rev (3m)-30.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)-6.38%
Revenue NY rev (3m)-18.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 6.86 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.11 | ||
| P/tB | 1.16 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-1.81
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.74
BVpS4.54
TBVpS4.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.15% | ||
| ROE | -8.41% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.88% | ||
| FCFM | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 988.05% | ||
| Cap/Sales | 235.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.96 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 0.92 |
F-Score2
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)4495.02%
Cap/Depr(5y)15899.7%
Cap/Sales(3y)642.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-152.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-330.73%
EPS Next 2Y0.84%
EPS Next 3Y50.21%
EPS Next 5Y81.13%
Revenue 1Y (TTM)205.07%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%68.54%
Revenue Next Year-27.75%
Revenue Next 2Y15.64%
Revenue Next 3Y39.62%
Revenue Next 5Y37.55%
EBIT growth 1Y-161.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-56473.6%
EBIT Next 3Y1328.21%
EBIT Next 5Y477.46%
FCF growth 1Y-44.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.05%
OCF growth 3YN/A
OCF growth 5YN/A
SALMON EVOLUTION ASA / SALME.OL FAQ
What is the fundamental rating for SALME stock?
ChartMill assigns a fundamental rating of 2 / 10 to SALME.OL.
What is the valuation status of SALMON EVOLUTION ASA (SALME.OL) stock?
ChartMill assigns a valuation rating of 1 / 10 to SALMON EVOLUTION ASA (SALME.OL). This can be considered as Overvalued.
Can you provide the profitability details for SALMON EVOLUTION ASA?
SALMON EVOLUTION ASA (SALME.OL) has a profitability rating of 1 / 10.
What is the financial health of SALMON EVOLUTION ASA (SALME.OL) stock?
The financial health rating of SALMON EVOLUTION ASA (SALME.OL) is 1 / 10.
What is the earnings growth outlook for SALMON EVOLUTION ASA?
The Earnings per Share (EPS) of SALMON EVOLUTION ASA (SALME.OL) is expected to decline by -330.73% in the next year.